BBC ETF
Virtus LifeSci Biotech Clinical Trials ETF
BBC ETF Overview
BBC ETF (Virtus LifeSci Biotech Clinical Trials ETF) is managed by Virtus Investment Partners with $38.8M in net assets. BBC expense ratio is 0.65%, holding 261 positions across sectors including Health Care, Industrials. Inception date: 2014-12-16.
BBC performance shows a YTD return of 22.15%. The 1-year return is 71.34% and the 5-year return is 2.71%. BBC dividend yield stands at 1.42%, paid annually.
BBC top holdings include Kodiak Sciences Inc (2.1%), Abcellera Biologics Inc. Common Shares (2.0%), Xencor Inc (1.5%), Amylyx Pharmaceuticals Inc Common Stock (1.4%), First Tracks Biotherapeutics, Inc. (1.4%). Go to all BBC holdings, BBC sectors, or BBC dividends.
BBC can be compared against other funds. Use BBC overlap to find shared positions, or BBC vs another fund for a side-by-side view. BBC alternatives are available via the screener, along with tax-loss harvesting opportunities.